In BLCA, studies have demonstrated that SCG2 promotes expansion, dissemination, and penetration of BLCA via activating MEK/Erk and MEK/IKK/NF-κB signaling routes and facilitating M2 macrophage polarization (Zhou et al., 2024). Here, SCG2 is linked to bladder transitional cell carcinoma.